Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.28
-0.03 (-0.41%)
Apr 29, 2026, 1:21 PM EDT - Market open
Kezar Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 71.88 | 41.75 | 35.49 | 40.46 | 62.88 | Upgrade
|
| Short-Term Investments | - | 90.5 | 165.88 | 236.11 | 145.47 | Upgrade
|
| Cash & Short-Term Investments | 71.88 | 132.25 | 201.37 | 276.56 | 208.36 | Upgrade
|
| Cash Growth | -45.65% | -34.33% | -27.19% | 32.73% | 48.35% | Upgrade
|
| Accounts Receivable | 1.74 | - | - | - | - | Upgrade
|
| Other Receivables | 0.18 | 0.42 | 2.29 | 0.77 | - | Upgrade
|
| Receivables | 1.93 | 0.42 | 2.29 | 0.77 | - | Upgrade
|
| Prepaid Expenses | 0.54 | 1.09 | 1.22 | 1.12 | 2.57 | Upgrade
|
| Other Current Assets | 1.39 | 3.73 | 2.07 | 7.27 | 0.73 | Upgrade
|
| Total Current Assets | 75.73 | 137.49 | 206.95 | 285.72 | 211.65 | Upgrade
|
| Property, Plant & Equipment | 0.92 | 4.78 | 8.69 | 13.17 | 6 | Upgrade
|
| Long-Term Accounts Receivable | - | 1.74 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | 0.67 | 5.6 | 0.67 | 0.28 | Upgrade
|
| Total Assets | 76.65 | 144.68 | 221.24 | 299.57 | 217.93 | Upgrade
|
| Accounts Payable | 0.51 | 3.65 | 8.25 | 2.48 | 2.03 | Upgrade
|
| Accrued Expenses | 3.74 | 7.94 | 6.48 | 5.95 | 4.99 | Upgrade
|
| Current Portion of Long-Term Debt | - | 5.22 | - | - | - | Upgrade
|
| Current Portion of Leases | 2.33 | 3.53 | 3.01 | 2.57 | 1.2 | Upgrade
|
| Total Current Liabilities | 6.57 | 20.33 | 17.74 | 11 | 8.21 | Upgrade
|
| Long-Term Debt | - | 5.11 | 10.07 | 9.83 | 9.62 | Upgrade
|
| Long-Term Leases | - | 2.33 | 5.85 | 8.87 | 3.22 | Upgrade
|
| Total Liabilities | 6.57 | 27.77 | 33.67 | 29.7 | 21.06 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.07 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 560.6 | 551.57 | 538.46 | 519.62 | 377.77 | Upgrade
|
| Retained Earnings | -490.53 | -434.5 | -350.76 | -248.89 | -180.65 | Upgrade
|
| Comprehensive Income & Other | - | -0.16 | -0.13 | -0.92 | -0.29 | Upgrade
|
| Total Common Equity | 70.07 | 116.92 | 187.57 | 269.87 | 196.88 | Upgrade
|
| Shareholders' Equity | 70.07 | 116.92 | 187.57 | 269.87 | 196.88 | Upgrade
|
| Total Liabilities & Equity | 76.65 | 144.68 | 221.24 | 299.57 | 217.93 | Upgrade
|
| Total Debt | 2.33 | 16.18 | 18.93 | 21.26 | 14.04 | Upgrade
|
| Net Cash (Debt) | 69.55 | 116.07 | 182.44 | 255.3 | 194.31 | Upgrade
|
| Net Cash Growth | -40.08% | -36.38% | -28.54% | 31.39% | 43.95% | Upgrade
|
| Net Cash Per Share | 9.51 | 15.92 | 25.15 | 37.90 | 36.83 | Upgrade
|
| Filing Date Shares Outstanding | 7.37 | 7.31 | 7.28 | 7.08 | 5.67 | Upgrade
|
| Total Common Shares Outstanding | 7.33 | 7.3 | 7.28 | 6.85 | 5.63 | Upgrade
|
| Working Capital | 69.16 | 117.16 | 189.21 | 274.73 | 203.44 | Upgrade
|
| Book Value Per Share | 9.56 | 16.01 | 25.77 | 39.40 | 34.99 | Upgrade
|
| Tangible Book Value | 70.07 | 116.92 | 187.57 | 269.87 | 196.88 | Upgrade
|
| Tangible Book Value Per Share | 9.56 | 16.01 | 25.77 | 39.40 | 34.99 | Upgrade
|
| Machinery | 0.18 | 5.85 | 5.84 | 4.67 | 3.67 | Upgrade
|
| Leasehold Improvements | 3.27 | 3.49 | 3.49 | 3.37 | 3.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.